Skip to content
Search

Latest Stories

Menopause treatment: 3 HRT medicines to be removed from HRT PPC list

Menopause treatment: 3 HRT medicines to be removed from HRT PPC list
Longjam Dineshwori
By Longjam DineshworiJul 29, 2024
Longjam Dineshwori

A passionate journalist with a keen interest in health and pharma, I strive to tell stories that inform, inspire, and drive meaningful change.

See Full Bio

Pharmacy staff are advised to check the NHSBSA website for the updated list of HRT medicine covered by the HRT PPC 

Community Pharmacy England (CPE) has notified pharmacy teams that starting 1 August 2024, three Hormone Replacement Therapy (HRT) medicines will be discontinued and will no longer be covered under the NHS HRT Prescription Prepayment Certificate (HRT PPC) scheme.

These are Bedol® 2mg tablets, Climanor® 5mg tablets and Clinorette® tablets.

Since Climanor® 5mg tablets have been discontinued, Medroxyprogesterone 5mg tablets will also be removed from the HRT PPC list, as this generic product is no longer available as a licensed HRT medicine.

The CPE also noted that Provera® 5mg tablets, being an unlicensed HRT medicine, are not covered by the HRT PPC.

Pharmacy staff are advised to check the NHS Business Services Authority (NHSBSA) website for the most current list of HRT medicines covered by the HRT PPC.

The CPE has updated its HRT PPC medicines list to reflect these changes, which will also be updated in Part XVI of the August 2024 Drug Tariff.

The HRT medicines list has been updated following consultation with the Medicines and Healthcare products Regulatory Agency (MHRA), NHSBSA and the NHS England Menopause Clinical Reference Group.

The list is regularly revised to include new HRT medicines licensed for menopause treatment in the UK or to remove those that are discontinued.

For any HRT medicines meeting the criteria that are missing from the list, pharmacy teams can contact dhsc.publicenquiries@dhsc.gov.uk.

In February 2023, the Department of Health and Social Care (DHSC) introduced the HRT prescription prepayment certificate (HRT PPC) to provide patients in England access to cheaper Hormone Replacement Therapy (HRT) for menopause.

Starting 1 April 2023, patients who do not qualify for exemption from NHS prescription charges could purchase an annual HRT PPC for the cost of two single prescription charges.

HRT PPCs only cover HRT medicines that are also licensed for the treatment of menopause in the UK.

“community pharmacy england”hrt medicinenhs business services authoritymenopause

Related News

Pharmacy owners to receive 19p SAF increase in advance payments for April and May 2025
News

19p SAF increase to be included in April and May 2025 advance payments

CPE invites pharmacy owners to share their views on new CPCF funding settlement
News

Pharmacy owners asked to share their views on new CPCF arrangements

Homecare medicines services face many challenges beyond pharmacy's control
News

GPhC calls for industry-wide collaboration to strengthen homecare medicines services

Standout moments from the Pharmacy Business Conference
Guest Blog

Embracing Disruption, Driving Success: Key takeaways from Pharmacy Business Conference

More For You

Lack of funding deters NI pharmacy contractors from expanding portfolio

W G Hamilton Pharmacy is the third pharmacy in Northern Ireland to be recently sold to first-time buyers.

Pharmacy ownership trends shift in Northern Ireland due to funding gap

An increasing number of pharmacies in Northern Ireland are being acquired by first-time buyers, as existing contractors and groups pull back from expanding their portfolios amid ongoing funding pressures, according to specialist business property adviser Christie & Co.

Among the most recent sales is W G Hamilton Pharmacy, a busy community pharmacy in Ballysillan, North Belfast.

Keep ReadingShow less
RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
© Copyright 2025 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc